Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
214 articles
1 of 22
NightWare revenue. Oui terminates trial. 2025 FDA guidance priorities, posteriorities
1.17.25
7
min. Read
NY Medicaid won’t pay for Freespira, CanvasDx. Insolvent Mahana’s first asset sale.
12.13.24
9
min. Read
Final Fee Schedule: How CMS tweaked its digital mental health treatment G-codes
11.01.24
5
min. Read
CMS prices MedRhythms InTandem. Big Health courts health systems
10.11.24
4
min. Read
Mahana Therapeutics’ insolvency. FDA clears Happy Ring (Tinder founder’s smart ring)
10.04.24
6
min. Read
Flashback: How Proteus Digital Health’s outcomes-based pricing worked for Tennessee Medicaid
9.20.24
5
min. Read
Are the Digital Mental Health Treatment G Codes necessary? Or RTM dupes?
7.12.24
7
min. Read
Which PDTs are still around? New bill in Congress.
6.28.24
10
min. Read
FDA OKs Alivecor (12L?), Akili OTC. Oui eyes obesity.
6.21.24
5
min. Read
Digging into the Akili-Virtual Therapeutics deal
5.31.24
10
min. Read
1 of 22